Clinical trial

Clevidipine in Neurocritical Patients

NCT05168059

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-01-01

PhaseN/A

Study timeline

Study start (actual)2017-01-01Date precision: day

Registry last updated2021-12-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

High Blood Pressureunresolved

Interventions

Clevidipine 0.5 MG/ML Intravenous EmulsionDRUG

Sponsors & collaborators

Hospital de Cruceslead sponsor

Biobizkaia Health Research Institutecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05168059 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.